| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
|
Stroke
|
2013
|
14.49
|
|
2
|
A trial of imaging selection and endovascular treatment for ischemic stroke.
|
N Engl J Med
|
2013
|
9.97
|
|
3
|
The impact of recanalization on ischemic stroke outcome: a meta-analysis.
|
Stroke
|
2007
|
8.06
|
|
4
|
Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial.
|
Stroke
|
2005
|
8.05
|
|
5
|
Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
|
N Engl J Med
|
2013
|
7.00
|
|
6
|
Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists.
|
Stroke
|
2009
|
6.62
|
|
7
|
Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.
|
Stroke
|
2009
|
5.91
|
|
8
|
Transient ischemic attack--proposal for a new definition.
|
N Engl J Med
|
2002
|
4.94
|
|
9
|
Comparison of MRI and CT for detection of acute intracerebral hemorrhage.
|
JAMA
|
2004
|
4.82
|
|
10
|
Statistical analysis of the primary outcome in acute stroke trials.
|
Stroke
|
2012
|
3.52
|
|
11
|
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.
|
Circulation
|
2011
|
3.30
|
|
12
|
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study.
|
Lancet Neurol
|
2010
|
2.87
|
|
13
|
Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging.
|
Stroke
|
2003
|
2.87
|
|
14
|
Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
|
Ann Intern Med
|
2013
|
2.87
|
|
15
|
Collateral flow predicts response to endovascular therapy for acute ischemic stroke.
|
Stroke
|
2011
|
2.80
|
|
16
|
Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application.
|
Stroke
|
2002
|
2.76
|
|
17
|
MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia.
|
Stroke
|
2004
|
2.75
|
|
18
|
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association.
|
Stroke
|
2013
|
2.66
|
|
19
|
Collaterals dramatically alter stroke risk in intracranial atherosclerosis.
|
Ann Neurol
|
2011
|
2.62
|
|
20
|
CT and MRI early vessel signs reflect clot composition in acute stroke.
|
Stroke
|
2011
|
2.52
|
|
21
|
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement.
|
Stroke
|
2013
|
2.50
|
|
22
|
Low glomerular filtration rate and risk of stroke: meta-analysis.
|
BMJ
|
2010
|
2.42
|
|
23
|
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity.
|
JAMA
|
2012
|
2.38
|
|
24
|
The smoking-thrombolysis paradox and acute ischemic stroke.
|
Neurology
|
2005
|
2.31
|
|
25
|
Late secondary ischemic injury in patients receiving intraarterial thrombolysis.
|
Ann Neurol
|
2002
|
2.31
|
|
26
|
Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead.
|
Stroke
|
2011
|
2.23
|
|
27
|
Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative.
|
Stroke
|
2011
|
2.19
|
|
28
|
Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials.
|
Stroke
|
2010
|
2.17
|
|
29
|
Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke.
|
Circulation
|
2010
|
2.15
|
|
30
|
Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue.
|
Stroke
|
2003
|
2.06
|
|
31
|
Effect of pre-diabetes on future risk of stroke: meta-analysis.
|
BMJ
|
2012
|
2.04
|
|
32
|
Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes.
|
J Neurosurg
|
2012
|
2.03
|
|
33
|
Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
2.02
|
|
34
|
Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke.
|
Stroke
|
2006
|
2.02
|
|
35
|
Dispatcher recognition of stroke using the National Academy Medical Priority Dispatch System.
|
Stroke
|
2009
|
1.96
|
|
36
|
Implementation strategies for emergency medical services within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association Expert Panel on Emergency Medical Services Systems and the Stroke Council.
|
Stroke
|
2007
|
1.94
|
|
37
|
Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies.
|
Stroke
|
2011
|
1.92
|
|
38
|
A midlife stroke surge among women in the United States.
|
Neurology
|
2007
|
1.86
|
|
39
|
Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.
|
Stroke
|
2014
|
1.76
|
|
40
|
Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis.
|
Stroke
|
2010
|
1.75
|
|
41
|
Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale.
|
Stroke
|
2009
|
1.72
|
|
42
|
Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials.
|
Cerebrovasc Dis
|
2009
|
1.71
|
|
43
|
Expanding indications for statins in cerebral ischemia: a quantitative study.
|
Arch Neurol
|
2005
|
1.69
|
|
44
|
Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis.
|
Stroke
|
2002
|
1.68
|
|
45
|
Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke.
|
Stroke
|
2011
|
1.67
|
|
46
|
Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program.
|
Circulation
|
2010
|
1.66
|
|
47
|
Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale.
|
Stroke
|
2009
|
1.63
|
|
48
|
Annual incidence of first silent stroke in the United States: a preliminary estimate.
|
Cerebrovasc Dis
|
2003
|
1.60
|
|
49
|
Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke.
|
Stroke
|
2006
|
1.59
|
|
50
|
Serial Alberta Stroke Program early CT score from baseline to 24 hours in Solitaire Flow Restoration with the Intention for Thrombectomy study: a novel surrogate end point for revascularization in acute stroke.
|
Stroke
|
2014
|
1.58
|
|
51
|
Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials.
|
Eur J Intern Med
|
2012
|
1.55
|
|
52
|
Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial.
|
Int J Stroke
|
2012
|
1.55
|
|
53
|
Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
1.54
|
|
54
|
Body mass index and hospital discharge outcomes after ischemic stroke.
|
Arch Neurol
|
2007
|
1.54
|
|
55
|
Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging.
|
Ann Neurol
|
2007
|
1.53
|
|
56
|
Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design.
|
Circulation
|
2011
|
1.51
|
|
57
|
Relationship of national institutes of health stroke scale to 30-day mortality in medicare beneficiaries with acute ischemic stroke.
|
J Am Heart Assoc
|
2012
|
1.48
|
|
58
|
Does achieving an intensive versus usual blood pressure level prevent stroke?
|
Ann Neurol
|
2011
|
1.48
|
|
59
|
Acute Stroke Imaging Research Roadmap II.
|
Stroke
|
2013
|
1.47
|
|
60
|
Risk of intracranial hemorrhage with protease-activated receptor-1 antagonists.
|
Stroke
|
2012
|
1.44
|
|
61
|
Multiparametric MRI and CT models of infarct core and favorable penumbral imaging patterns in acute ischemic stroke.
|
Stroke
|
2012
|
1.43
|
|
62
|
The new standing guideline committee policy of the American Stroke Association Stroke Council.
|
Stroke
|
2006
|
1.42
|
|
63
|
Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator.
|
Stroke
|
2012
|
1.41
|
|
64
|
Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts.
|
Stroke
|
2010
|
1.41
|
|
65
|
Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association.
|
Stroke
|
2013
|
1.41
|
|
66
|
The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI.
|
Stroke
|
2012
|
1.40
|
|
67
|
Early neutrophilia is associated with volume of ischemic tissue in acute stroke.
|
Stroke
|
2007
|
1.40
|
|
68
|
Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association.
|
Stroke
|
2009
|
1.38
|
|
69
|
Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices.
|
Cerebrovasc Dis
|
2008
|
1.37
|
|
70
|
Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies.
|
Stroke
|
2005
|
1.37
|
|
71
|
Thrombolytic toxicity: blood brain barrier disruption in human ischemic stroke.
|
Cerebrovasc Dis
|
2008
|
1.37
|
|
72
|
Evidence of publication bias in reporting acute stroke clinical trials.
|
Neurology
|
2006
|
1.37
|
|
73
|
Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials.
|
Stroke
|
2010
|
1.35
|
|
74
|
The Los Angeles Motor Scale (LAMS): a new measure to characterize stroke severity in the field.
|
Prehosp Emerg Care
|
2003
|
1.35
|
|
75
|
Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
1.31
|
|
76
|
Therapeutic milestone: stroke declines from the second to the third leading organ- and disease-specific cause of death in the United States.
|
Stroke
|
2010
|
1.28
|
|
77
|
In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up.
|
Stroke
|
2004
|
1.28
|
|
78
|
Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke.
|
Stroke
|
2010
|
1.28
|
|
79
|
Day-90 acute ischemic stroke outcomes can be derived from early functional activity level.
|
Cerebrovasc Dis
|
2009
|
1.24
|
|
80
|
A brief prehospital stroke severity scale identifies ischemic stroke patients harboring persisting large arterial occlusions.
|
Stroke
|
2008
|
1.24
|
|
81
|
Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial.
|
Stroke
|
2011
|
1.22
|
|
82
|
Cerebral white matter hyperintensities on MRI: Current concepts and therapeutic implications.
|
Cerebrovasc Dis
|
2006
|
1.21
|
|
83
|
Evolving paradigms in neuroimaging of the ischemic penumbra.
|
Stroke
|
2004
|
1.20
|
|
84
|
Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke - Comparison with dynamic susceptibility contrast enhanced perfusion imaging.
|
Neuroimage Clin
|
2013
|
1.20
|
|
85
|
Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke.
|
Stroke
|
2008
|
1.18
|
|
86
|
Stroke thrombolysis: save a minute, save a day.
|
Stroke
|
2014
|
1.17
|
|
87
|
Patterns of emergency medical services use and its association with timely stroke treatment: findings from Get With the Guidelines-Stroke.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
1.17
|
|
88
|
Impact of microalbuminuria on incident stroke: a meta-analysis.
|
Stroke
|
2010
|
1.17
|
|
89
|
Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke.
|
Stroke
|
2009
|
1.15
|
|
90
|
High-density lipoprotein cholesterol: an emerging target for stroke treatment.
|
Stroke
|
2007
|
1.14
|
|
91
|
Randomized, controlled trial of an intervention to enable stroke survivors throughout the Los Angeles County safety net to "stay with the guidelines".
|
Circ Cardiovasc Qual Outcomes
|
2011
|
1.11
|
|
92
|
Development and validation of a simple conversion model for comparison of intracerebral hemorrhage volumes measured on CT and gradient recalled echo MRI.
|
Stroke
|
2008
|
1.10
|
|
93
|
Swift or sure?: The acceptable rate of neurovascular mimics among IV tPA-treated patients.
|
Neurology
|
2010
|
1.09
|
|
94
|
Validation of computed tomographic middle cerebral artery "dot"sign: an angiographic correlation study.
|
Stroke
|
2003
|
1.08
|
|
95
|
Impact of baseline tissue status (diffusion-weighted imaging lesion) versus perfusion status (severity of hypoperfusion) on hemorrhagic transformation.
|
Stroke
|
2010
|
1.08
|
|
96
|
Collateral circulation in symptomatic intracranial atherosclerosis.
|
J Cereb Blood Flow Metab
|
2010
|
1.08
|
|
97
|
Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack.
|
Stroke
|
2003
|
1.08
|
|
98
|
Optimizing prediction scores for poor outcome after intra-arterial therapy in anterior circulation acute ischemic stroke.
|
Stroke
|
2013
|
1.07
|
|
99
|
Predictors of subarachnoid hemorrhage in acute ischemic stroke with endovascular therapy.
|
Stroke
|
2010
|
1.06
|
|
100
|
Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis.
|
Neurology
|
2006
|
1.05
|
|
101
|
Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization.
|
J Stroke Cerebrovasc Dis
|
2007
|
1.05
|
|
102
|
Hyperacute treatment initiation in neuroprotective agent stroke trials.
|
J Stroke Cerebrovasc Dis
|
2007
|
1.04
|
|
103
|
A risk score for in-hospital death in patients admitted with ischemic or hemorrhagic stroke.
|
J Am Heart Assoc
|
2013
|
1.04
|
|
104
|
Intra-arterial fibrinolysis for acute ischemic stroke: the message of melt.
|
Stroke
|
2007
|
1.04
|
|
105
|
Assessment and improvement of figures to visually convey benefit and risk of stroke thrombolysis.
|
Stroke
|
2010
|
1.04
|
|
106
|
Successful treatment of extensive cerebral venous sinus thrombosis using a combined approach with Penumbra aspiration system and Solitaire FR retrieval device.
|
J Neurointerv Surg
|
2013
|
1.03
|
|
107
|
Image-guided endoscopic evacuation of spontaneous intracerebral hemorrhage.
|
Surg Neurol
|
2008
|
1.02
|
|
108
|
Access to intra-arterial therapies for acute ischemic stroke: an analysis of the US population.
|
AJNR Am J Neuroradiol
|
2004
|
1.01
|
|
109
|
Years of optimum health lost due to complications after acute ischemic stroke: disability-adjusted life-years analysis.
|
Stroke
|
2010
|
1.01
|
|
110
|
Effect of time to reperfusion on clinical outcome of anterior circulation strokes treated with thrombectomy: pooled analysis of the MERCI and Multi MERCI trials.
|
Stroke
|
2011
|
1.01
|
|
111
|
Neuroprotective agents for the treatment of acute ischemic stroke.
|
Curr Neurol Neurosci Rep
|
2003
|
1.01
|
|
112
|
Endovascular treatment for acute ischemic stroke.
|
N Engl J Med
|
2013
|
1.00
|
|
113
|
FLAIR vascular hyperintensity may predict stroke after TIA.
|
Clin Neurol Neurosurg
|
2007
|
0.99
|
|
114
|
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.
|
Stroke
|
2015
|
0.98
|
|
115
|
Cryptogenic stroke and patent foramen ovale.
|
Curr Opin Cardiol
|
2008
|
0.98
|
|
116
|
Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event.
|
Stroke
|
2005
|
0.98
|
|
117
|
Recent nationwide trends in discharge statin treatment of hospitalized patients with stroke.
|
Stroke
|
2010
|
0.98
|
|
118
|
Frequency and determinants of nonpublication of research in the stroke literature.
|
Stroke
|
2006
|
0.97
|
|
119
|
Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy.
|
Stroke
|
2012
|
0.97
|
|
120
|
Impact of emergency medical services stroke routing protocols on Primary Stroke Center certification in California.
|
Stroke
|
2013
|
0.96
|
|
121
|
Level of albuminuria and risk of stroke: systematic review and meta-analysis.
|
Cerebrovasc Dis
|
2010
|
0.95
|
|
122
|
Strong independent correlation of proteinuria with cerebral microbleeds in patients with stroke and transient ischemic attack.
|
Arch Neurol
|
2010
|
0.95
|
|
123
|
Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
0.95
|
|
124
|
Multi-center prediction of hemorrhagic transformation in acute ischemic stroke using permeability imaging features.
|
Magn Reson Imaging
|
2013
|
0.94
|
|
125
|
Comparison of performance achievement award recognition with primary stroke center certification for acute ischemic stroke care.
|
J Am Heart Assoc
|
2013
|
0.94
|
|
126
|
Association of higher serum calcium levels with smaller infarct volumes in acute ischemic stroke.
|
Arch Neurol
|
2007
|
0.94
|
|
127
|
Symptomatic intracranial hemorrhage after stroke thrombolysis: comparison of prediction scores.
|
Stroke
|
2014
|
0.94
|
|
128
|
Translating evidence into practice: a decade of efforts by the American Heart Association/American Stroke Association to reduce death and disability due to stroke: a presidential advisory from the American Heart Association/American Stroke Association.
|
Stroke
|
2010
|
0.93
|
|
129
|
Prehospital stroke care: new prospects for treatment and clinical research.
|
Neurology
|
2013
|
0.92
|
|
130
|
Indices of kidney dysfunction and discharge outcomes in hospitalized stroke patients without known renal disease.
|
Cerebrovasc Dis
|
2009
|
0.92
|
|
131
|
Characteristics of patients with target magnetic resonance mismatch profile: data from two geographically and racially distinct populations.
|
Cerebrovasc Dis
|
2009
|
0.91
|
|
132
|
Stroke outcomes measures must be appropriately risk adjusted to ensure quality care of patients: a presidential advisory from the American Heart Association/American Stroke Association.
|
Stroke
|
2014
|
0.91
|
|
133
|
Treatment adherence rates one year after initiation of a systematic hospital-based stroke prevention program.
|
Cerebrovasc Dis
|
2005
|
0.91
|
|
134
|
Need to clarify Thrombolysis In Myocardial Ischemia (TIMI) scale scoring method in the Penumbra Pivotal Stroke Trial.
|
Stroke
|
2009
|
0.91
|
|
135
|
Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator.
|
Stroke
|
2005
|
0.90
|
|
136
|
Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke.
|
Stroke
|
2012
|
0.90
|
|
137
|
In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months.
|
J Stroke Cerebrovasc Dis
|
2008
|
0.90
|
|
138
|
Weighting components of composite end points in clinical trials: an approach using disability-adjusted life-years.
|
Stroke
|
2011
|
0.89
|
|
139
|
Leukoaraiosis and collaterals in acute ischemic stroke.
|
J Neuroimaging
|
2010
|
0.89
|
|
140
|
Serum calcium as prognosticator in ischemic stroke.
|
Stroke
|
2008
|
0.89
|
|
141
|
Blood-brain barrier permeability derangements in posterior circulation ischemic stroke: frequency and relation to hemorrhagic transformation.
|
J Neurol Sci
|
2011
|
0.89
|
|
142
|
Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: a case report.
|
Catheter Cardiovasc Interv
|
2005
|
0.89
|
|
143
|
Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis.
|
Atherosclerosis
|
2011
|
0.89
|
|
144
|
Basal ganglionic infarction before mechanical thrombectomy predicts poor outcome.
|
Stroke
|
2009
|
0.88
|
|
145
|
Contrast agent dose effects in cerebral dynamic susceptibility contrast magnetic resonance perfusion imaging.
|
J Magn Reson Imaging
|
2009
|
0.88
|
|
146
|
Dysphagia screening and hospital-acquired pneumonia in patients with acute ischemic stroke: findings from Get with the Guidelines--Stroke.
|
J Stroke Cerebrovasc Dis
|
2013
|
0.88
|
|
147
|
Patterns, predictors, variations, and temporal trends in emergency medical service hospital prenotification for acute ischemic stroke.
|
J Am Heart Assoc
|
2012
|
0.88
|
|
148
|
Effect of smoking status on outcome after acute ischemic stroke.
|
Cerebrovasc Dis
|
2006
|
0.87
|
|
149
|
The hyperdense vessel sign on CT predicts successful recanalization with the Merci device in acute ischemic stroke.
|
J Neurointerv Surg
|
2012
|
0.87
|
|
150
|
Association of serum bilirubin with ischemic stroke outcomes.
|
J Stroke Cerebrovasc Dis
|
2008
|
0.86
|
|
151
|
Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.
|
Circ Heart Fail
|
2012
|
0.86
|
|
152
|
Stunned brain syndrome: serial diffusion perfusion MRI of delayed recovery following revascularisation for acute ischaemic stroke.
|
J Neurol Neurosurg Psychiatry
|
2010
|
0.86
|
|
153
|
Developing practice recommendations for endovascular revascularization for acute ischemic stroke.
|
Neurology
|
2012
|
0.86
|
|
154
|
Evidence from the scene: paramedic perspectives on involvement in out-of-hospital research.
|
Ann Emerg Med
|
2012
|
0.86
|
|
155
|
Thrombus branching and vessel curvature are important determinants of middle cerebral artery trunk recanalization with Merci thrombectomy devices.
|
Stroke
|
2012
|
0.86
|
|
156
|
Impact of hyperlipidemia and statins on ischemic stroke outcomes after intra-arterial fibrinolysis and percutaneous mechanical embolectomy.
|
Cerebrovasc Dis
|
2009
|
0.85
|
|
157
|
Intraarterial treatment for acute ischemic stroke.
|
N Engl J Med
|
2015
|
0.85
|
|
158
|
Deriving number-needed-to-treat and number-needed-to-harm from the SAINT I trial results.
|
Stroke
|
2006
|
0.84
|
|
159
|
Boosting the chances to improve stroke treatment.
|
Stroke
|
2009
|
0.84
|
|
160
|
The ischemic stroke patient who worsens: new assessment and management approaches.
|
Rev Neurol Dis
|
2007
|
0.84
|
|
161
|
Differential pathophysiological mechanisms of stroke evolution between new lesions and lesion growth: perfusion-weighted imaging study.
|
Cerebrovasc Dis
|
2010
|
0.84
|
|
162
|
Treatment of high risk symptomatic intracranial atherosclerosis with balloon mounted coronary stents and Wingspan stents: single center experience over a 10 year period.
|
J Neurointerv Surg
|
2011
|
0.84
|
|
163
|
Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke.
|
J Neurol
|
2009
|
0.83
|
|
164
|
Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention.
|
J Stroke Cerebrovasc Dis
|
2007
|
0.83
|
|
165
|
Importance of proper patient selection and endpoint selection in evaluation of new therapies in acute stroke: further analysis of the SENTIS trial.
|
J Neurointerv Surg
|
2013
|
0.83
|
|
166
|
Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: data from a diverse race-ethnic group.
|
J Neurol Sci
|
2009
|
0.83
|
|
167
|
Evolution of reperfusion therapies for acute brain and acute myocardial ischemia: a systematic, comparative analysis.
|
Stroke
|
2012
|
0.83
|
|
168
|
Patent foramen ovale and stroke: what we do and don't know.
|
Rev Neurol Dis
|
2005
|
0.82
|
|
169
|
Predictors of cerebral microbleeds in acute ischemic stroke and TIA patients.
|
Cerebrovasc Dis
|
2006
|
0.82
|
|
170
|
Stent-Retriever Thrombectomy for Stroke.
|
N Engl J Med
|
2015
|
0.81
|
|
171
|
Ensuring management of vascular risk factors after stroke.
|
Rev Neurol Dis
|
2006
|
0.81
|
|
172
|
Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies.
|
Stroke
|
2004
|
0.81
|
|
173
|
Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
|
Stroke
|
2012
|
0.81
|
|
174
|
Endovascular stroke trials: why we must enroll all eligible patients.
|
Stroke
|
2013
|
0.81
|
|
175
|
Disability status at 1 month is a reliable proxy for final ischemic stroke outcome.
|
Neurology
|
2010
|
0.81
|
|
176
|
Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis.
|
Cerebrovasc Dis
|
2007
|
0.81
|
|
177
|
Factors associated with the steep increase in late-midlife stroke occurrence among US men.
|
J Stroke Cerebrovasc Dis
|
2008
|
0.81
|
|
178
|
Lipid assessment and treatment patterns in hospitalized TIA and ischemic stroke patients.
|
J Hosp Med
|
2006
|
0.81
|
|
179
|
Comparison of mechanical embolectomy and intraarterial thrombolysis in acute ischemic stroke within the MCA: MERCI and Multi MERCI compared to PROACT II.
|
Neurocrit Care
|
2008
|
0.81
|
|
180
|
Prior antiplatelet use and infarct volume in ischemic stroke.
|
J Neurol Sci
|
2007
|
0.81
|
|
181
|
Role of statin in atrial fibrillation-related stroke: an angiographic study for collateral flow.
|
Cerebrovasc Dis
|
2014
|
0.81
|
|
182
|
Reduction in early stroke risk in carotid stenosis with transient ischemic attack associated with statin treatment.
|
Stroke
|
2013
|
0.80
|
|
183
|
Beyond tissue plasminogen activator: mechanical intervention in acute stroke.
|
Ann Emerg Med
|
2003
|
0.80
|
|
184
|
Diagnosis of lacunar infarcts within 6 hours of onset by clinical and CT criteria versus MRI.
|
J Neuroimaging
|
2008
|
0.80
|
|
185
|
Association of laterality and size of perfusion lesions on neurological deficit in acute supratentorial stroke.
|
Int J Stroke
|
2011
|
0.80
|
|
186
|
Drip, Ship, and Grip, then Slice and Dice: Comprehensive Stroke Center Management of Cervical and Intracranial Emboli.
|
Front Neurol
|
2013
|
0.80
|
|
187
|
Intercontinental elicitation of informed consent for enrollment in stroke research.
|
Cerebrovasc Dis
|
2010
|
0.80
|
|
188
|
Anterior choroidal artery ischaemic patterns predict outcome of carotid occlusion.
|
J Neurol Neurosurg Psychiatry
|
2012
|
0.79
|
|
189
|
Warfarin Use and Risk of Stroke in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Meta-Analysis.
|
Medicine (Baltimore)
|
2016
|
0.79
|
|
190
|
Cerebral microbleeds after use of extracorporeal membrane oxygenation in children.
|
J Neuroimaging
|
2012
|
0.79
|
|
191
|
Achieving target cholesterol goals after stroke: is in-hospital statin initiation the key?
|
Arch Neurol
|
2006
|
0.79
|
|
192
|
Secondary-prevention drug prescription in the very elderly after ischemic stroke or TIA.
|
Neurology
|
2006
|
0.79
|
|
193
|
Age-distinct predictors of symptomatic cervicocephalic atherosclerosis.
|
Cerebrovasc Dis
|
2008
|
0.78
|
|
194
|
Outpatient practice patterns after stroke hospitalization among neurologists.
|
Stroke
|
2008
|
0.78
|
|
195
|
Withdrawal of warfarin prior to a surgical procedure: time to follow the guidelines?
|
Cerebrovasc Dis
|
2005
|
0.78
|
|
196
|
Endovascular recanalization in acute ischemic stroke: regionalized organization of care.
|
Neurology
|
2012
|
0.78
|
|
197
|
A care pathway to boost influenza vaccination rates among inpatients with acute ischemic stroke and transient ischemic attack.
|
J Stroke Cerebrovasc Dis
|
2009
|
0.78
|
|
198
|
Incomplete mechanical recanalization of middle cerebral artery occlusions facilitates endogenous recanalization within 5 h.
|
J Neurointerv Surg
|
2012
|
0.78
|
|
199
|
Cryptogenic Stroke.
|
N Engl J Med
|
2016
|
0.77
|
|
200
|
Mechanical thrombectomy devices for treatment of stroke.
|
Neurol Clin Pract
|
2012
|
0.77
|
|
201
|
Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke.
|
Stroke
|
2013
|
0.77
|
|
202
|
Utility of urinalysis in discriminating cardioembolic stroke mechanism.
|
Arch Neurol
|
2007
|
0.77
|
|
203
|
Renin-Angiotensin system modulators modestly reduce vascular risk in persons with prior stroke.
|
Stroke
|
2011
|
0.77
|
|
204
|
Optimizing an evidence-based causative classification system for ischemic stroke.
|
Ann Neurol
|
2006
|
0.76
|
|
205
|
Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial.
|
Stroke
|
2009
|
0.76
|
|
206
|
Mitochondrial encephalomyopathy with lactic acidosis and stroke (MELAS).
|
Rev Neurol Dis
|
2005
|
0.76
|
|
207
|
Prognostic value of Framingham Cardiovascular Risk Score in hospitalized stroke patients.
|
J Stroke Cerebrovasc Dis
|
2010
|
0.75
|
|
208
|
Comparison of plasmin with recombinant tissue-type plasminogen activator in lysis of cerebral thromboemboli retrieved from patients with acute ischemic stroke.
|
Stroke
|
2011
|
0.75
|
|
209
|
Comments on 'when to measure lipid profile after stroke'.
|
Cerebrovasc Dis
|
2004
|
0.75
|
|
210
|
New Cerebral Microbleeds After Mechanical Thrombectomy for Large-Vessel Occlusion Strokes.
|
Medicine (Baltimore)
|
2015
|
0.75
|
|
211
|
Aspirin and stroke severity.
|
Stroke
|
2006
|
0.75
|
|
212
|
Clinical trial registries.
|
JAMA
|
2007
|
0.75
|
|
213
|
Impact of Merci device fracture on clinical outcome of acute ischemic stroke after mechanical thrombectomy.
|
CNS Neurosci Ther
|
2012
|
0.75
|
|
214
|
Thrombolysis in stroke: a medicolegal quagmire.
|
Stroke
|
2006
|
0.75
|
|
215
|
Are racial differences in antihypertensive responsiveness reflected in usage after stroke?
|
J Stroke Cerebrovasc Dis
|
2007
|
0.75
|
|
216
|
Impact of reperfusion after 3 hours of symptom onset on tissue fate in acute cerebral ischemia.
|
J Neuroimaging
|
2008
|
0.75
|
|
217
|
Successful treatment of extensive cerebral venous sinus thrombosis using a combined approach with Penumbra aspiration system and Solitaire FR retrieval device.
|
BMJ Case Rep
|
2013
|
0.75
|
|
218
|
The THRIVE score strongly predicts outcomes in patients treated with the Solitaire device in the SWIFT and STAR trials.
|
Int J Stroke
|
2014
|
0.75
|
|
219
|
Effect of statin use on clinical outcomes in ischemic stroke patients with atrial fibrillation.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
220
|
Patent foramen ovale and cryptogenic stroke.
|
N Engl J Med
|
2013
|
0.75
|
|
221
|
Vision and creation of the American Heart Association pharmaceutical roundtable outcomes research centers.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
0.75
|
|
222
|
Response to: "A graphic reanalysis of the NINDS Trial".
|
Ann Emerg Med
|
2010
|
0.75
|
|
223
|
Renal dysfunction and discharge destination in patients with intracerebral hemorrhage.
|
J Stroke Cerebrovasc Dis
|
2010
|
0.75
|
|
224
|
Penumbral salvage and thrombolysis outcome: a drop of brain, a week of life.
|
Brain
|
2017
|
0.75
|
|
225
|
Optimizing screening and management of asymptomatic coronary artery disease in patients with stroke and patients with transient ischemic attack.
|
Stroke
|
2009
|
0.75
|
|
226
|
Patterns and predictors of discharge statin prescription among hospitalized patients with intracerebral hemorrhage.
|
Stroke
|
2010
|
0.75
|
|
227
|
Do high-density lipoprotein cholesterol levels influence stroke severity?
|
J Stroke Cerebrovasc Dis
|
2007
|
0.75
|
|
228
|
Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies.
|
EuroIntervention
|
2016
|
0.75
|
|
229
|
A comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIA.
|
Neurology
|
2003
|
0.75
|
|
230
|
Preprocedural basal ganglionic infarction increases the risk of hemorrhagic transformation but not worse outcome following successful recanalization of acute middle cerebral artery occlusions.
|
World Neurosurg
|
2010
|
0.75
|
|
231
|
JAMA Theme Issue on Neurology: Call for Papers.
|
JAMA
|
2013
|
0.75
|
|
232
|
A case of acute ischemic stroke: optimizing management with penumbra and vessel imaging.
|
Nat Clin Pract Neurol
|
2007
|
0.75
|
|
233
|
Intensive statin therapy after stroke or transient ischemic attack: a SPARCLing success?
|
Stroke
|
2007
|
0.75
|
|
234
|
Influence of height on the clinical characteristics and prognosis of patients with ischemic stroke.
|
Neurologist
|
2011
|
0.75
|
|
235
|
Clinical performance measures for adults hospitalized with acute ischemic stroke: performance measures for healthcare professionals from the American Heart Association/American Stroke Association.
|
Stroke
|
2014
|
0.75
|